IFI spring newsletter 2025

genai image of floating envelopes

IFI Insights: Tracking the evolution of AI with patents

From AI to GenAI and now Agentic AI, IFI has tracked the patents to see which companies are leading the way in the new age of AI and the innovative technologies they are developing. To learn more about the current AI patent landscape globally and in the U.S., click here.

genai image of circuit board with AI letters on top


3 new countries added to CLAIMS Direct

GenAI image of globe

IFI is proud to announce the additions of Cyprus, Moldova and Montenegro to its full text patent data collection! These additions bring IFI’s full text patent coverage to 58 countries. For an overview of IFI’s patent data coverage, click here.

South Korean Snapshots added to CLAIMS Direct

IFI Snapshots provide an easy, accurate and effective method of obtaining critical insights of a patent document, including the expiry date, legal status and more. Recently IFI has added Snapshot coverage for South Korea bringing total IFI Snapshot coverage to 11 countries. Learn more about IFI Snapshots here.

VIew of Korean peninsula from space

The IFI Interview: Erre Quadro

Errequadro logo

Erre Quadro brings engineering design methodology to the study of patents. Advantages of this discipline abound for the company. Among them? Pinpointing information in the text with a high degree of accuracy. And speeding the reading–and searching–of the patent document. We caught up with Donata Gabelloni, Head of Research and Development at Erre Quadro to find out more. Click here for the full interview.

IFI Insights: Anti-obesity drugs – which pharmaceuticals carry the most patent weight?

Increasing innovation in GLP-1 agonists has led to an increase in patent activity over the last year. IFI explored the elements of weight loss drug-related patents to discover who is currently leading the way in the space. For the full report, click here.

Photo of jars in a lab